Nelsilene Mota Carvalho

Control of endometriosis-associated pain with etonogestrel-releasing contraceptive implant and 52-mg levonorgestrel-releasing intrauterine system: randomized clinical trial

Nelsilene Mota Carvalho, Deborah Margatho, Kleber Cursino et al. · Fertility and Sterility · 2018 · 91 citations · Full text

Medicine, Gynecology, Obstetrics +17

Endometriosis-associated pain scores and biomarkers in users of the etonogestrel-releasing subdermal implant or the 52-mg levonorgestrel-releasing intrauterine system for up to 24 months

Deborah Margatho, Nelsilene Mota Carvalho, Luís Bahamondes · The European Journal of Contraception & Reproductive Health Care · 2020 · 39 citations

Medicine, Gynecology, Obstetrics +17

Relationship between user satisfaction with the levonorgestrel‐releasing intrauterine system and bleeding patterns

Nelsilene Mota Carvalho, Victoria B. Chou, Waleska Modesto et al. · Journal of obstetrics and gynaecology research · 2017 · 26 citations

Medicine, Gynecology, Obstetrics +17

Assessment of biomarkers in women with endometriosis-associated pain using the ENG contraceptive implant or the 52 mg LNG-IUS: a non-inferiority randomised clinical trial

Deborah Margatho, Nelsilene Mota Carvalho, Larissa Eloy et al. · The European Journal of Contraception & Reproductive Health Care · 2018 · 16 citations

Medicine, Gynecology, Obstetrics +17

A randomized controlled pilot study of ulipristal acetate for abnormal bleeding among women using the 52‐mg levonorgestrel intrauterine system

Mariana Lacerda Fava, Alessandra Peloggia, Luiz Francisco Baccaro et al. · International Journal of Gynecology & Obstetrics · 2019 · 15 citations · Full text

Medicine, Gynecology, Pharmacology +14